The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL

Author:

Stachelscheid Johanna123ORCID,Jiang Qu123,Aszyk Christoph123,Warner Kathrin14,Bley Nadine5ORCID,Müller Tony123,Vydzhak Olga123,Symeonidis Konstantinos123,Crispatzu Giuliano123,Mayer Petra123,Blakemore Stuart James123,Goehring Gudrun6,Newrzela Sebastian4,Hippler Stephanie1,Robrecht Sandra1,Kreuzer Karl-Anton1,Pallasch Christian123ORCID,Krüger Marcus23ORCID,Lechner Axel7,Fischer Kirsten1,Stilgenbauer Stephan89,Beutner Dirk7,Hallek Michael123,Auguin Daniel1011ORCID,Hüttelmaier Stefan5,Bloehdorn Johannes8ORCID,Vasyutina Elena123,Herling Marco12312

Affiliation:

1. 1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University Hospital Cologne, Cologne, Germany

2. 2Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany

3. 3Cologne Excellence Cluster on Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany

4. 4Senckenberg Institute of Pathology, Goethe-University, Frankfurt am Main, Germany

5. 5Section for Molecular Cell Biology, Institute of Molecular Medicine, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Charles Tanford Protein Center, Halle, Germany

6. 6Institute of Human Genetics, Hannover Medical School, Hannover, Germany

7. 7Department of Otorhinolaryngology, University of Göttingen, Göttingen, Germany

8. 8Department of Internal Medicine III, Ulm University, Ulm, Germany

9. 9Department of Internal Medicine I, Saarland University Medical Center, Homburg, Germany

10. 10Université d'Orléans, INRA, USC1328, Orléans, France

11. 11Structural Motility, Institut Curie, Paris Université Sciences et Lettres, Sorbonne Université, CNRS, Paris, France

12. 12Department of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig, Leipzig, Germany

Abstract

Abstract Upregulation of the proto-oncogene T-cell leukemia/lymphoma 1A (TCL1A) is causally implicated in various B-cell and T-cell malignancies. High-level TCL1A correlates with aggressive disease features and inferior clinical outcomes. However, the molecular and cell biological consequences of, particularly nuclear, TCL1A are not fully elucidated. We observed here in mouse models of subcellular site-specific TCL1A-induced lymphomagenesis that TCL1A exerts a strong transforming impact via nuclear topography. In proteomic screens of TCL1A-bound molecules in chronic lymphocytic leukemia (CLL) cells and B-cell lymphoma lines, we identified regulators of cell cycle and DNA repair pathways as novel TCL1A interactors, particularly enriched under induced DNA damage and mitosis. By functional mapping and in silico modeling, we specifically identified the mitotic checkpoint protein, cell division cycle 20 (CDC20), as a direct TCL1A interactor. According to the regulatory impact of TCL1A on the activity of the CDC20-containing mitotic checkpoint and anaphase-promoting complexes during mitotic progression, TCL1A overexpression accelerated cell cycle transition in B-cell lymphoma lines, impaired apoptotic damage responses in association with pronounced chromosome missegregation, and caused cellular aneuploidy in Eμ-TCL1A mice. Among hematopoietic cancers, CDC20 levels seem particularly low in CLL. CDC20 expression negatively correlated with TCL1A and lower expression marked more aggressive and genomically instable disease and cellular phenotypes. Knockdown of Cdc20 in TCL1A-initiated murine CLL promoted aneuploidy and leukemic acceleration. Taken together, we discovered a novel cell cycle–associated effect of TCL1A abrogating controlled cell cycle transition. This adds to our concept of oncogenic TCL1A by targeting genome stability. Overall, we propose that TCL1A acts as a pleiotropic adapter molecule with a synergistic net effect of multiple hijacked pathways.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference59 articles.

1. Identification of the TCL1 gene involved in T-cell malignancies;Virgilio;Proc Natl Acad Sci U S A,1994

2. Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL;Schrader;Nat Commun,2018

3. Molecular basis of CLL;Pekarsky;Semin Cancer Biol,2010

4. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state;Herling;Leukemia,2006

5. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia;Herling;Blood,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3